NCT01396889

Impact of Echinacea as Prophilaxis for Upper Respiratory Tract Infections in Children 1-5 Years

Impact of Echinacea as Prophilaxis for Upper Respiratory Tract Infections in Children 1-5 Years in Bandarabbas Children' Hospital

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: Hormozgan University of Medical Sciences · Academic / Other
• Sex: All
• Age: 1 Year – 5 Years
• Healthy volunteers: Accepted

Summary

Acute upper respiratory tract infections are the most commmon infections in children and are associated with complications such as acute otitis media, sinusitis and pneumonia. Echinacea is widely used for treatment of upper respiratoty tract infections. The aim of this study is to evaluate its efficacy as prophilaxis in children 1-5 years old.

Conditions

• Upper Respiratory Tract Infections

Interventions

Type	Name	Description
DRUG	Echinacea	0.5ml daily for children 1-2 years old and 2ml daily for children 2-5 years old
DRUG	Placebo	Placebo (0.5ml daily for children 1-2 years old and 2ml daily for children 2-5 years old) for 3 months

Timeline

• Start date: 2010-05-01
• Primary completion: 2010-12-01
• Completion: 2011-07-01
• First posted: 2011-07-19
• Last updated: 2011-07-22

Locations

1 site across 1 country: Iran